Search references for SYNAPTOSOME. Phrases containing SYNAPTOSOME
See searches and references containing SYNAPTOSOME!SYNAPTOSOME
Isolated synaptic terminal from a neuron
A synaptosome is an isolated synaptic terminal from a neuron. Synaptosomes are obtained by mild homogenization of nervous tissue under isotonic conditions
Synaptosome
Withdrawn antidepressant medication
Nomifensine, formerly sold under the brand names Merital and Alival, is a norepinephrine–dopamine reuptake inhibitor (NDRI) drug that was developed in
Nomifensine
Neurotransmitters that are released at the synapse
"Victor P. Whittaker: The Discovery of the Synaptosome and Its Implications". The discovery of the synaptosome and its implications. Vol. 141. New York
Synaptic_vesicle
Broad-spectrum calcium channel blocker
inhibits glutamate release, calcium uptake and also glutamate uptake in synaptosomes. Currently, it is known to naturally occur only in the venom of the spider
Phoneutria nigriventer toxin-3
Phoneutria_nigriventer_toxin-3
Class of compounds
proteins, synaptosomes possess all of the cellular machinery necessary for neurotransmitter synthesis, release, metabolism, and reuptake. Synaptosomes, however
Monoamine_releasing_agent
Pharmaceutical compound
serotonin, 25 nM for norepinephrine, and 21–28 nM for dopamine in rat brain synaptosomes. The drug produces hyperlocomotion in rodents comparably to but with
3-Bromomethcathinone
Pharmaceutical compound
6,340 nM for norepinephrine, and 5,840 nM for dopamine in rat brain synaptosomes. HMMC was first described in the scientific literature by 2011. 3
4-Hydroxy-3-methoxymethcathinone
4-Hydroxy-3-methoxymethcathinone
Pharmaceutical compound
releasing activities of a series of methcathinone analogs in male rat brain synaptosomes". Psychopharmacology (Berl). 236 (3): 915–924. doi:10.1007/s00213-018-5063-9
1-Naphthylmethcathinone
Pharmaceutical compound
half-maximal effective concentration values of 295 nM and 2,100 nM in rat brain synaptosomes, whereas norepinephrine release was not reported. In contrast to many
BK-5Br-NM-AMT
Pharmaceutical compound
serotonin, 28.5 nM for norepinephrine, and 16.8 nM for dopamine in rat brain synaptosomes. 7-APBT was first described in the scientific literature by 2020. Substituted
7-APBT
Medication used to treat amyotrophic lateral sclerosis
"Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes". Brain Research. 871 (2): 175–180. doi:10.1016/S0006-8993(00)02430-6
Riluzole
Pharmaceutical compound
half-maximal effective concentration values of 200 nM and 865 nM in rat brain synaptosomes, whereas norepinephrine release was not reported. In contrast to many
BK-5Cl-NM-AMT
Chemical compound
performed by Michael Baumann and Donna Walther and was likely rat brain synaptosomes (including comparison with previously published data from this assay)
BK-5-MAPB
Process of synapse elimination
uptake has been specifically observed to be upregulated in the isolated synaptosomes of male patients with schizophrenia compared to healthy controls, suggesting
Synaptic_pruning
Chemical compound
dopamine, 75 nM for norepinephrine, and 301 nM for serotonin in rat brain synaptosomes. Hence, it releases dopamine about 3-fold more potently than norepinephrine
3-Chlorophenmetrazine
Pharmaceutical compound
380 nM for dopamine, and >10,000 nM for norepinephrine in rat brain synaptosomes. Tryptamines without substitutions at the amine or alpha carbon, such
7-Methyltryptamine
SNRI medication
for further studies, because it inhibited serotonin reuptake in rat synaptosomes to twice the degree of the (–)-enantiomer. This molecule was subsequently
Duloxetine
Pharmaceutical compound
serotonin, 327 nM for norepinephrine, and 496 nM for dopamine in rat brain synaptosomes. These potencies were about 1.4-fold, 2.2-fold, and 3.7-fold lower than
3,4-Ethylenedioxymethcathinone
3,4-Ethylenedioxymethcathinone
Psychoactive substance found in plants in the family Apocynaceae
effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes". Brain Research Bulletin. 48 (6): 641–647. doi:10.1016/s0361-9230(99)00053-2
Ibogaine
Chemical compound
the blood–brain barrier while showing a low neurotoxicity on rat brain synaptosomes. Colon HT-29 tumour cells were also sensitive towards this organic compound
Avarol
Never-marketed drug of the amphetamine family
drug releases the neurotransmitter. The assays were done in rat brain synaptosomes and human potencies may be different. See also Monoamine releasing agent
Norfenfluramine
Psychoactive stimulant and norepinephrine releasing agent
norepinephrine, 1,355 nM for dopamine, and >10,000 nM for serotonin in rat brain synaptosomes. It is dramatically less potent as an MRA than phenethylamine or amphetamine
Phenylalaninol
Pharmaceutical compound
353 nM for dopamine, and >10,000 nM for norepinephrine in rat brain synaptosomes. It shows extremely weak affinity for the dizocilpine (MK-801) site of
6-Methyltryptamine
Protein found in humans
Synaptosome-associated protein, 47 kDal (SNAP47) is a human protein encoded by the SNAP47 gene. Other aliases of this gene are SVAP1, HEL170, ESFI5812
SNAP47
Benzodiazepine medication
Chlordiazepoxide inhibits acetylcholine release in mouse hippocampal synaptosomes in vivo. This has been found by measuring sodium-dependent high affinity
Chlordiazepoxide
Chemical compound
2009). "Inhibitory effect of glutamate release from rat cerebrocortical synaptosomes by dextromethorphan and its metabolite 3-hydroxymorphinan". Neurochemistry
3-Hydroxymorphinan
Protein found in humans
scutatus scutatus) on acetylcholine release and compartmentation in synaptosomes from electric organ of Torpedo marmorata". Toxicon. 28 (9): 1039–52.
Choline_transporter
Class of chemical compounds
the compound produces the effect. The assays were done in rat brain synaptosomes and human potencies may be different. See also Monoamine releasing agent
Substituted_2-aminoindane
Chemical compound
release are 166 nM for dopamine and 867 nM for norepinephrine in rat brain synaptosomes, whereas serotonin was not reported. The drug has been found to robustly
Para-Methoxyamphetamine
Pharmaceutical compound
novel designer drug in Europe in 2016. In studies evaluating rat brain synaptosomes in vitro, 4-CEC demonstrated a strong preference for interacting with
4-Chloroethcathinone
Chemical compound
releaser of dopamine with a maximal efficacy of about 40% in rat brain synaptosomes. In another study however, DEPEA non-significantly released norepinephrine
N,α-Diethylphenethylamine
Monoamine releaser and entactogen
release are 41.3 nM for serotonin and 92.8 nM for dopamine in rat brain synaptosomes, whereas it only induced 55% release of norepinephrine at a concentration
BK-NM-AMT
Anticonvulsant medication
IC50 values are 240μM (5-HT, human platelets), 474 μM (5-HT, rat brain synaptosomes), 239 μM (norepinephrine) and 322 μM (dopamine). Lamotrigine blocks NMDA
Lamotrigine
Class of medications
of antiepileptic drugs on GABA release from rat and human neocortical synaptosomes". Naunyn-Schmiedeberg's Archives of Pharmacology. 384 (1): 47–57. doi:10
Anticonvulsant
Enclosing or separating membrane in organisms acting as selective semi-permeable barrier
COPI-coated and COPII-coated vesicles) and secretory vesicles (including synaptosome, acrosomes, melanosomes, and chromaffin granules). Different types of
Biological_membrane
Pharmaceutical compound
norepinephrine, 1,860 nM for dopamine, and >60,000 nM for serotonin in rat brain synaptosomes. βk-NMPEA was first described in the scientific literature by 2019. Phenylethanolamine
Β-Keto-N-methylphenethylamine
Pharmaceutical compound
serotonin, 33 nM for norepinephrine, and 250 nM for dopamine in rat brain synaptosomes. The drug was first described in the scientific literature by 2012.
Ortho-Bromophenylpiperazine
Pharmaceutical compound
methamphetamine) and no significant release of dopamine in rat brain synaptosomes. As such, its monoamine-releasing activity was said to have been essentially
Homo-MDMA
Synthetic opioid pain medication
M, Mennini T (April 1999). "Release studies with rat brain cortical synaptosomes indicate that tramadol is a 5-hydroxytryptamine uptake blocker and not
Tramadol
characterized by their binding to two separate receptor sites on rat brain synaptosomes". Biochemical and Biophysical Research Communications. 95 (4): 1607–14
BotIT2
Psychoactive drug, often called ecstasy
releases monoamines is species-dependent. For example, in rat brain synaptosomes, MDMA preferentially releases 5-HT with modest selectivity (<10-fold)
MDMA
Pharmaceutical compound
serotonin, 113 nM for dopamine, and 465 nM for norepinephrine in rat brain synaptosomes. It is also a full agonist of the serotonin 5-HT2A receptor, but with
6-Methoxytryptamine
Class of transmembrane transporter protein
while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes". The Journal of Neuroscience. 35 (13): 5187–5201. doi:10.1523/jneurosci
Antiporter
Pharmaceutical compound
norepinephrine, 590 nM for dopamine, and 12,860 nM for serotonin in rat brain synaptosomes. α-Methylmethcathinone was first described in the scientific literature
Α-Methylmethcathinone
Synthetic hallucinogen
25I-NBOMe has been found to increase dopamine release from mouse striatal synaptosomes similarly to methamphetamine in vitro. Likewise, 25I-NBOMe has been found
25I-NBOMe
Chemical compound
serotonin, 24 nM for norepinephrine, and 41 nM for dopamine using rat brain synaptosomes. It is also a partial agonist of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C
5-MAPB
Chemical compound
releasing activities of a series of methcathinone analogs in male rat brain synaptosomes". Psychopharmacology (Berl). 236 (3): 915–924. doi:10.1007/s00213-018-5063-9
Α-Methyltryptamine
Stimulant drug
Reid LR (June 1980). "Competitive inhibition of catecholamine uptake in synaptosomes of rat brain by rigid bicyclo-octanes". Journal of Neurochemistry. 34
LR-5182
Pharmaceutical drug
alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes". The Journal of Neuroscience. 20 (8): 2783–91. doi:10.1523/JNEUROSCI
UB-165
Pharmaceutical compound
"Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates"
4-Methoxyphenethylamine
Pharmaceutical compound
norepinephrine, 90 nM for dopamine, and 14,100 nM for serotonin in rat brain synaptosomes. HHMC was first described in the scientific literature by 2017.
3,4-Dihydroxymethcathinone
Pharmaceutical compound
serotonin, 106 nM for dopamine, and 1,123 nM for norepinephrine in rat brain synaptosomes. Tryptamines without substitutions at the amine or alpha carbon, such
4-Fluorotryptamine
Endogenous inhibitory neurosteroid
modulate nicotinic receptor function in mouse striatal and thalamic synaptosomes". Journal of Neurochemistry. 68 (6): 2412–2423. doi:10.1046/j.1471-4159
Allopregnanolone
Protein-coding gene in the species Homo sapiens
well as by progesterone. The protein encoded by this gene contains a t-synaptosome-associated protein receptor (SNARE) coiled-coil homology domain and a
DEPP1
Medication for nausea, psychosis, and anxiety
antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake". European
Prochlorperazine
Protein-coding gene in humans
SNAP29 Identifiers Aliases SNAP29, CEDNIK, SNAP-29, synaptosome associated protein 29kDa, synaptosome associated protein 29 External IDs OMIM: 604202; MGI:
SNAP29
Medication used to treat seizures
drug releases the neurotransmitter. The assays were done in rat brain synaptosomes and human potencies may be different. See also Monoamine releasing agent
Fenfluramine
Psychoactive drug
inhibiting the reuptake of serotonin, dopamine, and norepinephrine in rat synaptosomes. In animal studies it substitutes for MBDB, MMAI, LSD, and 2
6-Methyl-MDA
Class of compounds in the nervous system
cells and WT mouse and monkey striatal synaptosomes but not in DAT-only transfected cells or in striatal synaptosomes of TAAR1-KO mice (Xie & Miller, 2009)
Monoaminergic activity enhancer
Monoaminergic_activity_enhancer
British neurochemist
preparations ranging from purified glycolytic-enzymes to tissue-homogenates, synaptosomes, brain slices and even anaesthetized live-animals. Much of this work
Herman_S._Bachelard
Mobile genetic element found in prokaryotes
sub-site, come together to form a large complex structure called the synaptosome. Resolvase bound to sites II and III initiates the assembly of this complex
Tn3_transposon
Pharmaceutical compound
476 nM for dopamine, and >10,000 nM for norepinephrine in rat brain synaptosomes. Similarly to tryptamine and other simple amine-unsubstituted tryptamines
5-Chlorotryptamine
Stimulant designer drug
releasing activities of a series of methcathinone analogs in male rat brain synaptosomes". Psychopharmacology. 236 (3): 915–924. doi:10.1007/s00213-018-5063-9
3-Chloromethcathinone
Trace amine
drug releases the neurotransmitter. The assays were done in rat brain synaptosomes and human potencies may be different. See also Monoamine releasing agent
Phenethylamine
Pharmaceutical compound
including of serotonin, norepinephrine, and dopamine, in rat brain synaptosomes (all EC50 = >10,000 nM), but was a very low-potency serotonin reuptake
4-Methoxytryptamine
Chemical compound
dopamine, 26 nM for norepinephrine, and 3,349 nM for serotonin in rat brain synaptosomes. Similarly, MDPV's IC50 values for monoamine reuptake inhibition were
Methylenedioxypyrovalerone
Canadian neuroscientist
Health Research (CIHR) grant selection panels and was the editor of the Synaptosomes book (ISBN 978-1-4939-8738-2) published in 2018 in the NeuroMethods Series
Kathryn_Mary_Murphy
Chemical compound
releasing activities of a series of methcathinone analogs in male rat brain synaptosomes". Psychopharmacology. 236 (3): 915–924. doi:10.1007/s00213-018-5063-9
Cathinone
Pharmaceutical compound
concentration values for induction of monoamine release in rat brain synaptosomes have been reported for the individual enantiomers of 6-MBPB. In the case
6-MBPB
Pharmaceutical compound
dopamine, 105 nM for norepinephrine, and 567 nM for serotonin in rat brain synaptosomes. Hence, 3-CC shows almost 10-fold preference for induction of dopamine
3-Chlorocathinone
Pharmaceutical compound
concentration value for induction of serotonin release in rat brain synaptosomes was 21 nM, whereas norepinephrine and dopamine release were not reported
4-Methylthiomethamphetamine
Entactogen drug
releasing activities of a series of methcathinone analogs in male rat brain synaptosomes". Psychopharmacology. 236 (3): 915–924. doi:10.1007/s00213-018-5063-9
Methylone
Comprehensive map of neural connections in the brain
Outline of brain mapping Outline of the human brain Lesion network mapping Synaptosome History of microscale connectomics Horn A, Ostwald D, Reisert M, Blankenburg
Connectome
Sympathomimetic nasal decongestant (Phenethylamine group)
values of 154 nM for norepinephrine and 574 nM for dopamine in rat brain synaptosomes, whereas serotonin was not reported. β,N,N-Trimethylphenethylamine Methamphetamine
Phenpromethamine
Pharmaceutical compound
of 1,337 nM and an EmaxTooltip maximal efficacy of 67% in rat brain synaptosomes. Conversely, it was inactive on dopamine, whereas serotonin was not reported
Β,N,N-Trimethylphenethylamine
Chemical compound
is a potent inhibitor of norepinephrine uptake in rat brain synaptosomes, reverses reserpine induced hypothermia in mice, and blocks uptake of
Tametraline
Tamapin-2 can also compete very effectively with apamin for binding to synaptosomes. The target of tamapin is the small conductance calcium-dependent potassium
Tamapin
Pharmaceutical compound
2,118 nM for dopamine, and 5,600 nM for norepinephrine in rat brain synaptosomes. The effects of 7-methoxytryptamine in rodents have been described. Tryptamines
7-Methoxytryptamine
Pharmaceutical compound
half-maximal effective concentration values of 190 nM and 620 nM in rat brain synaptosomes, whereas norepinephrine release was not reported. In contrast to many
BK-5F-NM-AMT
Pharmaceutical compound
MDMA. MDMP failed to act as a serotonin releasing agent in rat brain synaptosomes in vitro. The chemical synthesis of MDMP has been described. This substance
3,4-Methylenedioxy-N-methylphentermine
3,4-Methylenedioxy-N-methylphentermine
Medication used for other purposes that additionally has analgesic effects
of antiepileptic drugs on GABA release from rat and human neocortical synaptosomes". Naunyn-Schmiedeberg's Archives of Pharmacology. 384 (1): 47–57. doi:10
Analgesic_adjuvant
Type of drug
releasing activities of a series of methcathinone analogs in male rat brain synaptosomes". Psychopharmacology (Berl). 236 (3): 915–924. doi:10.1007/s00213-018-5063-9
Dopamine_releasing_agent
Major metabolite of rasagiline
(March 1972). "Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine". The Journal of Pharmacology
(R)-1-Aminoindane
Pharmaceutical compound
EC50Tooltip half-maximal effective concentration of 4.4 nM in rat brain synaptosomes. It was more potent as an SRA than any other tryptamine in large series
6-Fluorotryptamine
Benzodiazepine sedative
preparations. Diazepam inhibits acetylcholine release in mouse hippocampal synaptosomes. This has been found by measuring sodium-dependent high-affinity choline
Diazepam
Chemical compound
norepinephrine release, and 597 nM for dopamine release in rat brain synaptosomes. Compared to MDMA, EDMA was about half as potent as a serotonin releaser
EDMA
Class of chemical compounds
norepinephrine releasing profiles for various cathinones, measured in rat brain synaptosomes. The derivatives may be produced by substitutions at four locations of
Substituted_cathinone
Central nervous system stimulant
drug releases the neurotransmitter. The assays were done in rat brain synaptosomes and human potencies may be different. See also Monoamine releasing agent
Methamphetamine
Phenethylamine derivative
releasing activities of a series of methcathinone analogs in male rat brain synaptosomes". Psychopharmacology. 236 (3): 915–924. doi:10.1007/s00213-018-5063-9
2-Aminoacetophenone
Type of receptor located in the membranes of nerve cells
Monoamine Autoreceptors in Human Embryonic Kidney 293 Cells and Brain Synaptosomes". Journal of Pharmacology and Experimental Therapeutics. 325 (2): 629–640
Autoreceptor
Pharmaceutical compound
660 nM. It has also been found to induce dopamine release in rat striatal synaptosomes. It has been hypothesized that 1-ethyl-β-carboline might contribute to
1-Ethyl-β-carboline
Chemical compound
releasing activities of a series of methcathinone analogs in male rat brain synaptosomes". Psychopharmacology (Berl). 236 (3): 915–924. doi:10.1007/s00213-018-5063-9
Methamnetamine
Pharmaceutical compound
serotonin, 656 nM for norepinephrine, and 1,330 nM for dopamine in rat brain synaptosomes. The drug is one of the most potent SRAs in vitro known, after 6-fluorotryptamine
7-Chlorotryptamine
Chemical compound
drug releases the neurotransmitter. The assays were done in rat brain synaptosomes and human potencies may be different. See also Monoamine releasing agent
MDMAR
Class of drugs
Anticonvulsant; weak SNDRI; IC50 is 240μM (human platelets) / 474 μM (rat brain synaptosomes) for SERT, 239 μM for NET, 322 μM for DAT Mepiprazole BMS-866949 (made
Serotonin–norepinephrine–dopamine reuptake inhibitor
Serotonin–norepinephrine–dopamine_reuptake_inhibitor
Pharmaceutical compound
norepinephrine release. The monoamine release assays were performed in rat brain synaptosomes. Several close analogues of 5-chloro-αET, including 5-chloro-αMT and
5-Chloro-αET
Recreational drug
releasing activities of a series of methcathinone analogs in male rat brain synaptosomes". Psychopharmacology. 236 (3). Berl: 915–924. doi:10.1007/s00213-018-5063-9
Mephedrone
Pharmaceutical compound
dramatically less potent than phenethylamine as an NDRA in rat brain synaptosomes in vitro and shows ~7-fold preference for induction of norepinephrine
Phenylpropylamine
Discontinued anorexiant
drug releases the neurotransmitter. The assays were done in rat brain synaptosomes and human potencies may be different. See also Monoamine releasing agent
Phenmetrazine
Mammalian protein found in Homo sapiens
proteins, synaptosomes possess all of the cellular machinery necessary for neurotransmitter synthesis, release, metabolism, and reuptake. Synaptosomes, however
Vesicular monoamine transporter 2
Vesicular_monoamine_transporter_2
travel, tourism, insurance
SYNAPTOSOME
SYNAPTOSOME
SYNAPTOSOME
SYNAPTOSOME
SYNAPTOSOME
SYNAPTOSOME
SYNAPTOSOME
SYNAPTOSOME
SYNAPTOSOME
travel, tourism, insurance